243 related articles for article (PubMed ID: 15389871)
1. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells.
Lee OK; Ko YC; Kuo TK; Chou SH; Li HJ; Chen WM; Chen TH; Su Y
J Cell Biochem; 2004 Nov; 93(5):917-28. PubMed ID: 15389871
[TBL] [Abstract][Full Text] [Related]
2. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells.
Sugiyama M; Kodama T; Konishi K; Abe K; Asami S; Oikawa S
Biochem Biophys Res Commun; 2000 May; 271(3):688-92. PubMed ID: 10814523
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro.
Jäger M; Fischer J; Dohrn W; Li X; Ayers DC; Czibere A; Prall WC; Lensing-Höhn S; Krauspe R
J Orthop Res; 2008 Nov; 26(11):1440-8. PubMed ID: 18404732
[TBL] [Abstract][Full Text] [Related]
4. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
5. Fluvastatin and lovastatin inhibit granulocyte macrophage-colony stimulating factor-stimulated human eosinophil adhesion to inter-cellular adhesion molecule-1 under flow conditions.
Robinson AJ; Kashanin D; O'Dowd F; Fitzgerald K; Williams V; Walsh GM
Clin Exp Allergy; 2009 Dec; 39(12):1866-74. PubMed ID: 19689459
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes.
Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Weitz-Schmidt G; Nishibori M
J Leukoc Biol; 2005 Mar; 77(3):400-7. PubMed ID: 15618295
[TBL] [Abstract][Full Text] [Related]
7. Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation.
Chang SA; Lee EJ; Kang HJ; Zhang SY; Kim JH; Li L; Youn SW; Lee CS; Kim KH; Won JY; Sohn JW; Park KW; Cho HJ; Yang SE; Oh WI; Yang YS; Ho WK; Park YB; Kim HS
Stem Cells; 2008 Jul; 26(7):1901-12. PubMed ID: 18403756
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
9. Effect of HMGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line.
Bertrand-Thiebault C; Masson C; Siest G; Batt AM; Visvikis-Siest S
J Cardiovasc Pharmacol; 2007 May; 49(5):306-15. PubMed ID: 17513950
[TBL] [Abstract][Full Text] [Related]
10. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J
Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS
J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163
[TBL] [Abstract][Full Text] [Related]
12. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.
Wong WW; Tan MM; Xia Z; Dimitroulakos J; Minden MD; Penn LZ
Clin Cancer Res; 2001 Jul; 7(7):2067-75. PubMed ID: 11448925
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Nakamura H
Cancer Res; 2001 Jun; 61(12):4885-91. PubMed ID: 11406567
[TBL] [Abstract][Full Text] [Related]
14. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
15. Effect of HMG-CoA reductase inhibitors on activation of human gammadeltaT cells induced by Mycobacterium tuberculosis antigens.
Lü HZ; Li BQ
Immunopharmacol Immunotoxicol; 2009; 31(3):485-91. PubMed ID: 19555197
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis.
Nagashima T; Okazaki H; Yudoh K; Matsuno H; Minota S
Arthritis Rheum; 2006 Feb; 54(2):579-86. PubMed ID: 16447234
[TBL] [Abstract][Full Text] [Related]
17. Lipophilic statins can be osteogenic by promoting osteoblastic calcification in a Cbfa1- and BMP-2-independent manner.
Izumo N; Fujita T; Nakamuta H; Koida M
Methods Find Exp Clin Pharmacol; 2001 Sep; 23(7):389-94. PubMed ID: 11771853
[TBL] [Abstract][Full Text] [Related]
18. Pulsed electromagnetic fields enhance BMP-2 dependent osteoblastic differentiation of human mesenchymal stem cells.
Schwartz Z; Simon BJ; Duran MA; Barabino G; Chaudhri R; Boyan BD
J Orthop Res; 2008 Sep; 26(9):1250-5. PubMed ID: 18404656
[TBL] [Abstract][Full Text] [Related]
19. Stimulatory effects of statins on bone marrow-derived mesenchymal stem cells. Study of a new therapeutic agent for fracture.
Sonobe M; Hattori K; Tomita N; Yoshikawa T; Aoki H; Takakura Y; Suguro T
Biomed Mater Eng; 2005; 15(4):261-7. PubMed ID: 16010034
[TBL] [Abstract][Full Text] [Related]
20. Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction.
Takahashi HK; Iwagaki H; Yagi T; Kanke T; Liu K; Yoshino T; Tanaka N; Nishibori M
Clin Immunol; 2007 Jun; 123(3):324-32. PubMed ID: 17482516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
